Elypta logo

Elypta

Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.

5

Funding Rounds

$56.7m

Money raised

Overview

Elypta is a Stockholm-based biotechnology company focused on preventing cancer mortality through a liquid biopsy platform for detection and monitoring of the disease.

Funding

Funding series

Funding Series Analysis

The company Elypta has raised a total of $55.4m in funding over 5 rounds.

Key Insights:

  • Elypta Series A round, June 2022: $21m
  • Elypta June 2022 Series A Funding Round: $21m
  • Elypta , January 2020: $6.7m
  • Elypta January 2020 Seed Funding Round: $6.7m
Elypta logo
Elypta Series A round, June 2022 $21m
Elypta logo
Elypta June 2022 Series A Funding Round $21m
Elypta logo
Elypta , January 2020 $6.7m
Elypta logo
Elypta January 2020 Seed Funding Round $6.7m